Physiomics (LON:PYC – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported GBX (0.20) EPS for the quarter, Digital Look Earnings reports. Physiomics had a negative return on equity of 152.03% and a negative net margin of 74.06%.
Physiomics Price Performance
LON:PYC traded down GBX 0.02 on Friday, reaching GBX 0.45. The stock had a trading volume of 1,502,172 shares, compared to its average volume of 5,668,300. The company has a market cap of £2.05 million, a price-to-earnings ratio of -3.02 and a beta of 1.05. The firm’s fifty day moving average is GBX 0.49 and its two-hundred day moving average is GBX 0.51. Physiomics has a 12-month low of GBX 0.25 and a 12-month high of GBX 0.80.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
See Also
- Five stocks we like better than Physiomics
- RTX Locks In a Decade of Defense Dominance
- Okeanis Riding Record Profits as Uncertainty Grows
- Securitize’s Blockchain Ambitions Face a Reality Check
- 3 Stocks to Watch as Wall Street Wealth Fuels Consumer Spending
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
